Brian Zietsman
Finanzdirektor/CFO bei Enteris BioPharma, Inc.
Profil
Brian Zietsman is currently the President & Chief Financial Officer at Enteris BioPharma, Inc. Prior to this, he was the Chief Financial Officer, Secretary & Treasurer at Unigene Laboratories, Inc. from 2012 to 2013.
He completed his undergraduate degree at Rhodes University.
Aktive Positionen von Brian Zietsman
| Unternehmen | Position | Beginn |
|---|---|---|
Enteris BioPharma, Inc.
 Enteris BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Enteris BioPharma, Inc. operates as a clinical stage biopharmaceutical company. It offers formulation solutions built around its proprietary oral drug delivery technologies. The company was founded in 2013 and is headquartered in Boonton, NJ. | Finanzdirektor/CFO | - |
Ehemalige bekannte Positionen von Brian Zietsman
| Unternehmen | Position | Ende |
|---|---|---|
| UNIGENE LABORATORIES INC | Finanzdirektor/CFO | 02.07.2013 |
Ausbildung von Brian Zietsman
| Rhodes University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Unigene Laboratories, Inc.
 Unigene Laboratories, Inc. Pharmaceuticals: OtherHealth Technology Unigene Laboratories, Inc. was a biopharmaceutical company, which engaged in the designing, delivering, manufacturing and development of peptide-based therapeutics. The company was founded by Jay Levy, Ronald S. Levy and Warren P. Levy on October 31, 1980 and was headquartered in Boonton, NJ. | Health Technology |
Enteris BioPharma, Inc.
Enteris BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Enteris BioPharma, Inc. operates as a clinical stage biopharmaceutical company. It offers formulation solutions built around its proprietary oral drug delivery technologies. The company was founded in 2013 and is headquartered in Boonton, NJ. | Health Technology |